Asthma is a common lung condition that affects 5.4 million people in the UK and can lead to symptoms such as coughing, wheezing or feeling breathless. Asthma is… read more.
Despite considerable advances in the understanding of asthma and the treatments available, at least three deaths each day in the UK are due to asthma. In this series… read more.
Pharmacists bring a special and distinctive set of skills to the care of people with asthma and it is an area that can offer a stimulating and rewarding… read more.
Steroid stewardship is an important task for respiratory pharmacists and is one of the measures that can have a positive impact on the overall outcomes of asthma explains… read more.
There are numerous opportunities for pharmacists to work in respiratory medicine across the whole spectrum of health care in a variety of roles, according to Dr Anna Murphy,… read more.
As an independent prescriber Dr Anna Murphy, Consultant Respiratory Pharmacist, keenly aware that she is accountable for what she prescribes. Here, she describes how she uses her pharmaceutical… read more.
Three deaths each day in the UK are due to asthma despite considerable advances in the understanding of the disease and the treatments available. IMI spoke to Dr… read more.
If you’ve ever struggled to breathe, you’ve had a moment of hypoxia — a lack of oxygen. Hypoxia can have long-term effects. In fact, doctors describe hypoxia as… read more.
Amgen announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed Tezspire (tezepelumab-ekko) demonstrated reductions in the annualized asthma… read more.
The FDA has approved Dupixent (dupilumab), from Sanofi + Regeneron, as an add-on maintenance treatment of patients aged 6 to 11 years with moderate-to-severe asthma characterized by an… read more.
Patients with asthma often experience a worsening of asthmatic symptoms at night in so-called “nocturnal asthma.” According to reports, more than 50% of asthma deaths occur at night,… read more.
The biologic drug dupilumab lowers the rate of severe asthma attacks and improves lung function and asthma control for children ages 6 to 11, researchers reported on December 9, 2021 in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
